These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


142 related items for PubMed ID: 6092901

  • 1. Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes.
    Howlett AC, Fleming RM.
    Mol Pharmacol; 1984 Nov; 26(3):532-8. PubMed ID: 6092901
    [Abstract] [Full Text] [Related]

  • 2. Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes.
    Howlett AC.
    Mol Pharmacol; 1985 Apr; 27(4):429-36. PubMed ID: 2984538
    [Abstract] [Full Text] [Related]

  • 3. Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs.
    Howlett AC, Qualy JM, Khachatrian LL.
    Mol Pharmacol; 1986 Mar; 29(3):307-13. PubMed ID: 2869405
    [Abstract] [Full Text] [Related]

  • 4. Modification of receptor-mediated inhibition of adenylate cyclase in NG108-15 neuroblastoma X glioma cells by n-ethylmaleimide.
    Smith MM, Harden TK.
    J Pharmacol Exp Ther; 1984 Feb; 228(2):425-33. PubMed ID: 6319678
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds.
    Howlett AC.
    Life Sci; 1984 Oct 22; 35(17):1803-10. PubMed ID: 6090851
    [Abstract] [Full Text] [Related]

  • 6. Regulation of adenylate cyclase by chronic exposure to cannabimimetic drugs.
    Dill JA, Howlett AC.
    J Pharmacol Exp Ther; 1988 Mar 22; 244(3):1157-63. PubMed ID: 2855242
    [Abstract] [Full Text] [Related]

  • 7. Studies of the role of membrane lipid order in the effects of delta 9-tetrahydrocannabinol on adenylate cyclase activation in heart.
    Hillard CJ, Pounds JJ, Boyer DR, Bloom AS.
    J Pharmacol Exp Ther; 1990 Mar 22; 252(3):1075-82. PubMed ID: 2156989
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of forskolin activated adenylate cyclase in hamster adipocyte membranes with prostaglandin E1 and clonidine.
    McMahon KK, Schimmel RJ.
    J Cyclic Nucleotide Res; 1982 Mar 22; 8(1):39-47. PubMed ID: 6890078
    [Abstract] [Full Text] [Related]

  • 9. Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model.
    Howlett AC, Johnson MR, Melvin LS, Milne GM.
    Mol Pharmacol; 1988 Mar 22; 33(3):297-302. PubMed ID: 3352594
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
    Schatz AR, Lee M, Condie RB, Pulaski JT, Kaminski NE.
    Toxicol Appl Pharmacol; 1997 Feb 22; 142(2):278-87. PubMed ID: 9070350
    [Abstract] [Full Text] [Related]

  • 12. Regulation of adenylate cyclase by cannabinoid drugs. Insights based on thermodynamic studies.
    Howlett AC, Scott DK, Wilken GH.
    Biochem Pharmacol; 1989 Oct 01; 38(19):3297-304. PubMed ID: 2554920
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Possible role of prostaglandins in the effects of the cannabinoids on adenylate cyclase activity.
    Hillard CJ, Bloom AS.
    Eur J Pharmacol; 1983 Jul 15; 91(1):21-7. PubMed ID: 6311573
    [Abstract] [Full Text] [Related]

  • 15. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.
    Little PJ, Compton DR, Johnson MR, Melvin LS, Martin BR.
    J Pharmacol Exp Ther; 1988 Dec 15; 247(3):1046-51. PubMed ID: 2849657
    [Abstract] [Full Text] [Related]

  • 16. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
    Prather PL, Tsai AW, Law PY.
    J Pharmacol Exp Ther; 1994 Jul 15; 270(1):177-84. PubMed ID: 8035314
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation.
    Jeon YJ, Yang KH, Pulaski JT, Kaminski NE.
    Mol Pharmacol; 1996 Aug 15; 50(2):334-41. PubMed ID: 8700141
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.
    Barovsky K, Pedone C, Brooker G.
    Mol Pharmacol; 1984 Mar 15; 25(2):256-60. PubMed ID: 6321948
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.